Quest Diagnostics Incorporated

NYSE:DGX Stock Report

Market Cap: US$18.0b

Quest Diagnostics Future Growth

Future criteria checks 1/6

Quest Diagnostics is forecast to grow earnings and revenue by 11.7% and 4.9% per annum respectively. EPS is expected to grow by 11.1% per annum. Return on equity is forecast to be 15.5% in 3 years.

Key information

11.7%

Earnings growth rate

11.1%

EPS growth rate

Healthcare earnings growth20.8%
Revenue growth rate4.9%
Future return on equity15.5%
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Oct 25
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

Apr 26
Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

Recent updates

Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)

Nov 12
Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)

Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Oct 25
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

Oct 24

Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Oct 23
Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly

Oct 15

These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Aug 30
These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Aug 12
Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Quest Diagnostics: Beat Down After Beating Q2 Estimates

Jul 28

The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Jul 12
The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics: On A Quest For Growth

Jul 12

Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

May 14
Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

Quest Diagnostics: Let's Keep Waiting

May 08

Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

Apr 26
Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Apr 23
We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Apr 02
Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Mar 15
Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75

Feb 06
Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75

Quest Diagnostics: Post-COVID Normalization Pretty Much Done

Feb 05

Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Jan 11
Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price

Dec 24
Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price

Quest Diagnostics: Market Overreaction Creates Investment Opportunity

Dec 08

Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?

Dec 06
Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall

Nov 18
Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall

Quest Diagnostics: Moving Past Covid

Oct 25

Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly

Sep 25
Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly

What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Sep 04
What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues

Aug 15

Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

Aug 13
Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Jul 11
Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Jun 09
Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Quest Diagnostics: Healthier Diagnosis

May 30

Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?

May 24
Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

May 09
Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued

Mar 22
An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued

What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Feb 19
What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Earnings and Revenue Growth Forecasts

NYSE:DGX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202611,0031,0891,3301,76013
12/31/202510,6351,0011,0901,49416
12/31/20249,8339069151,30513
9/30/20249,5398381,0231,397N/A
6/30/20249,3468368751,248N/A
3/31/20249,2878429471,332N/A
12/31/20239,2528508641,272N/A
9/30/20239,2977595961,079N/A
6/30/20239,4887908781,374N/A
3/31/20239,6037898641,332N/A
12/31/20229,8839421,3141,718N/A
9/30/202210,2941,2301,4641,865N/A
6/30/202210,5821,4791,5521,924N/A
3/31/202210,6791,8741,6021,982N/A
12/31/202110,7881,9881,8302,233N/A
9/30/202111,0462,1751,8722,293N/A
6/30/202111,0582,2382,1712,594N/A
3/31/202110,3351,7942,0682,489N/A
12/31/20209,4371,4251,5872,005N/A
9/30/20208,3611,1011,3841,812N/A
6/30/20207,5317498161,249N/A
3/31/20207,6577717791,215N/A
12/31/20197,7268358431,243N/A
9/30/20197,6397098111,190N/A
6/30/20197,5727079291,293N/A
3/31/20197,5387209381,295N/A
12/31/20187,5317338171,200N/A
9/30/20187,5578609141,228N/A
6/30/20187,524808N/A1,188N/A
3/31/20187,469782N/A1,159N/A
12/31/20177,402769N/A1,175N/A
9/30/20177,398671N/A1,156N/A
6/30/20177,427701N/A1,095N/A
3/31/20177,469702N/A1,112N/A
12/31/20167,214642N/A1,116N/A
9/30/20167,503675N/A1,037N/A
6/30/20167,498825N/A948N/A
3/31/20167,517748N/A922N/A
12/31/20157,493706N/A821N/A
9/30/20157,527703N/A852N/A
6/30/20157,551491N/A911N/A
3/31/20157,528507N/A906N/A
12/31/20147,435549N/A944N/A
9/30/20147,308506N/A845N/A
6/30/20147,192780N/A761N/A
3/31/20147,105799N/A689N/A
12/31/20137,146811N/A652N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DGX's forecast earnings growth (11.7% per year) is above the savings rate (2.6%).

Earnings vs Market: DGX's earnings (11.7% per year) are forecast to grow slower than the US market (15.3% per year).

High Growth Earnings: DGX's earnings are forecast to grow, but not significantly.

Revenue vs Market: DGX's revenue (4.9% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: DGX's revenue (4.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: DGX's Return on Equity is forecast to be low in 3 years time (15.5%).


Discover growth companies